abstract |
The present invention relates to novel, biologically active, stabilized adrenomedullin (ADM) compounds. The invention further relates to medicaments comprising a compound for the treatment and / or prophylaxis of diseases, in particular cardiovascular, edematous and / or inflammatory disorders, and for the treatment and / or prevention of cardiovascular, edematous and / or inflammatory disorders. |